Rallybio financial statements

랠리바이오NASDAQ:RLYB · Nasdaq · Healthcare · sector #16
$17.08+1.07%
2026-10-06 close · prelim

Rallybio's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$63M.

Reported results

Rallybio notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q